On the heals of the newly expanded recall of Am2Pat pre-filled hepain syringes for bacterial contamination, another manufacturer (Baxter) has annnounced a recall nearly 10% of its yearly heparin production. The press is implying a link to the case filed by actor Dennis Quaid over the overdosing of his two infant children by poorly labeled heparin, but the vials involved are actually different. Nine lots of Baxter’s heparin (a blood thinner) were recalled by Baxter International Inc after an increase in reports of adverse reactions in patients. Also, California regulators recently criticized Cedars Sanai Hospital for the over-prescription of heparin. See article.
Patients who received the Am3Pat heparin syringes contaminated with Serratia marcescens have suffered serious infection. Our law firm is about file some of the first lawsuits for patients who have suffered permanent injuries from this contaminated product.
Comments for this article are closed.